Literature DB >> 33832610

Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial.

Ilaria Cavallari, Deepak L Bhatt, Ph Gabriel Steg, Lawrence A Leiter, Darren K McGuire, Ofri Mosenzon, Kyungah Im, Itamar Raz, Eugene Braunwald, Benjamin M Scirica.   

Abstract

Entities:  

Year:  2021        PMID： 33832610     DOI： 10.1016/j.jacc.2021.02.030

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  In Vitro Investigation of Binding Interactions between Albumin-Gliclazide Model and Typical Hypotensive Drugs.

Authors:  Ewa Zurawska-Plaksej; Rafal Wiglusz; Agnieszka Piwowar; Katarzyna Wiglusz
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

2.  GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off.

Authors:  Dario Giugliano; Lorenzo Scappaticcio; Miriam Longo; Giuseppe Bellastella; Katherine Esposito
Journal:  Cardiovasc Diabetol       Date:  2021-10-12       Impact factor: 9.951

3.  Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study.

Authors:  Jiahang Li; Zhenxing Nie; Zhongli Ge; Lei Shi; Bin Gao; Yan Yang
Journal:  Lipids Health Dis       Date:  2022-08-25       Impact factor: 4.315

4.  Characteristics, survival and neurological outcome in out-of-hospital cardiac arrest: A nationwide study of 56,203 cases with emphasis on cardiovascular comorbidities.

Authors:  Araz Rawshani; Fredrik Hessulf; Sebastian Völz; Christian Dworeck; Jacob Odenstedt; Truls Råmunddal; Geir Hirlekar; Petur Petursson; Oskar Angerås; Dan Ioanes; Anna Myredal
Journal:  Resusc Plus       Date:  2022-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.